DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease

Phase 4

Terminated

Conditions: Peripheral Artery Disease

Interventions: Drug: Metformin 1000 mg
Drug: Placebo

First Posted Date: 2013-07-17

Last Posted Date: 2018-09-24

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 2

Registration Number: NCT01901224

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care

Not Applicable

Conditions: HIV

Interventions: Other: Same-Day HIV testing and ART initiation
Other: Standard ART Initiation

First Posted Date: 2013-07-16

Last Posted Date: 2016-10-11

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 814

Registration Number: NCT01900080

Locations: 🇭🇹
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation

Phase 2

Terminated

Conditions: Humoral Rejection
Antibody-mediated Rejection

Interventions: Biological: Immunoglobulin
Drug: Eculizumab
Procedure: Plasmapheresis

First Posted Date: 2013-07-10

Last Posted Date: 2017-09-21

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 11

Registration Number: NCT01895127

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
University of Michigan Medical Center, Ann Arbor, Michigan, United States

The Effects of the Food Preservative Propionic Acid in Post-prandial Metabolism

Not Applicable

Conditions: Obesity
Insulin Resistance
Diabetes

Interventions: Dietary Supplement: Calcium propionate

First Posted Date: 2013-06-28

Last Posted Date: 2014-09-22

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 20

Registration Number: NCT01889446

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Walnut Consumption, Endothelial Function, and Biomarkers

Not Applicable

Completed

Conditions: Type 2 Diabetes
Coronary Heart Disease

Interventions: Other: Once ounce per day of walnuts

First Posted Date: 2013-06-24

Last Posted Date: 2016-03-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 26

Registration Number: NCT01884363

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)

Not Applicable

Conditions: Dry Eye Disease

Interventions: Drug: Omega-3 fatty acids (fish oil)
Dietary Supplement: Vitamin D3 placebo
Dietary Supplement: Vitamin D3
Drug: Fish oil placebo

First Posted Date: 2013-06-19

Last Posted Date: 2019-07-30

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 25875

Registration Number: NCT01880463

Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2

Conditions: Parkinson's Disease

First Posted Date: 2013-06-04

Last Posted Date: 2016-01-12

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 76

Registration Number: NCT01867788

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effects of Light on Melatonin and Contractions in Pregnant Women

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Device: Lighting2
Device: Lighting1

First Posted Date: 2013-05-29

Last Posted Date: 2024-08-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 51

Registration Number: NCT01863446

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy

Phase 1

Completed

Conditions: Senile Cardiac Amyloidosis
Amyloidosis; Heart (Manifestation)

Interventions: Drug: Tauroursodeoxycholic Acid and Doxycycline

First Posted Date: 2013-05-16

Last Posted Date: 2020-12-04

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 40

Registration Number: NCT01855360

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD

Phase 4

Withdrawn

Conditions: End Stage Renal Disease
Hemodialysis

Interventions: Drug: Spironolactone
Drug: Placebo
Dietary Supplement: L-arginine

First Posted Date: 2013-05-16

Last Posted Date: 2017-05-04

Lead Sponsor: Brigham and Women's Hospital

Registration Number: NCT01855334

Locations: 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy